Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Anaptysbio Inc patents


Recent patent applications related to Anaptysbio Inc. Anaptysbio Inc is listed as an Agent/Assignee. Note: Anaptysbio Inc may have other listings under different names/spellings. We're not affiliated with Anaptysbio Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Anaptysbio Inc-related inventors


Antibodies directed against t cell immunoglobulin and mucin protein 3 (tim-3)

The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to a protein encoded by the t cell immunoglobulin and mucin protein-3 (hm-3). The invention provides a tim-3-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. ... Anaptysbio Inc

Antibodies directed against lymphocyte activation gene 3 (lag-3)

The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to a protein encoded by the lymphocyte activation gene-3 (lag-3). The invention provides a lag-3-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. ... Anaptysbio Inc

Antibodies directed against interleukin 36 receptor (il-36r)

The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to a protein encoded by the interleukin 36 receptor (il-36r). The invention provides an il-36r-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. ... Anaptysbio Inc

Antibodies directed against programmed death-1 (pd-1)

The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to a programmed death-1 (pd-1) protein. The invention provides a pd-1-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. ... Anaptysbio Inc

Antibodies directed against discoidin domain receptor family, member 1 (ddr1)

The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to discoidin domain receptor family, member 1 (ddr1). The invention provides a ddr1-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. ... Anaptysbio Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Anaptysbio Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Anaptysbio Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###